We are thrilled to announce CSL Behring as a Champion level Impact Sponsor of the Foundation for Peripheral Neuropathy (FPN). Their generous support and commitment to our cause are crucial in advancing our mission. CSL Behring is a global leader in biotherapeutics, dedicated to improving the quality of life for patients with rare and serious …
Announcing Our Renewed Partnership with CSL Behring Read More »
Does diabetic peripheral neuropathic pain (DPNP) disrupt your daily life and keep you awake at night despite your current treatment? You are not alone. The NEPTUNE-17 clinical trial, hosted by the Foundation for Peripheral Neuropathy Research Impact’s partner, GSK, offers a potential new option for managing DPNP symptoms. You may be eligible to participate in …
Join the NEPTUNE-17 clinical trial for Diabetic Peripheral Neuropathic Pain (DPNP) Read More »
We are thrilled to announce a new partnership between the Foundation for Peripheral Neuropathy (FPN) and GlaxoSmithKline (GSK) as a 2024 Research Impact Partner. This collaboration, with GSK’s generous support, marks a significant step forward in our mission to improve the lives of those living with peripheral neuropathy. Expanding our reach Since our establishment in …
Announcing Our New Partnership with GlaxoSmithKline (GSK) Read More »
We are honored to announce that on May 16, 2024, the Foundation for Peripheral Neuropathy (FPN) received an extraordinary and transformational donation of over $660,000. This unprecedented gift, given posthumously, is the largest single contribution in our organization’s history. While the donor has chosen to remain anonymous, we wish to honor and celebrate their remarkable …
The Foundation for Peripheral Neuropathy Receives Largest Gift to Date Read More »
The Foundation for Peripheral Neuropathy (FPN) is pleased to announce the 2024-25 cycle of our early career research grants, offered through the American Academy of Neurology (AAN) and American Brain Foundation (ABF). This grant is called the Clinical Research Training Scholarship in Peripheral Neuropathy (CRTS in PN). The goal of this funding mechanism is to …
Meet Jason B., a husband, father, supporter of FPN, and an SFN patient, as he shares his journey living with peripheral neuropathy. January 2, 1994, 24 years old, a recent college grad. I was flying from San Francisco to home in San Diego when I felt an unusual, cold yet burning sensation in my legs. …
Living with Peripheral Neuropathy: A 30-Year Journey of Challenges and Hope Read More »
By Sumedha ShastryHave you ever been watching TV and stumbled upon an advertisement promoting an 80s aerobics class—filled with bright workout outfits and groovy background music? For many, it brings back memories of decades past, when Jane Fonda and Arnold Schwarzenegger were iconic television figures; for others, like me, it exposes life before YouTube workout …
By Stacey Udell, PN patient and FPN supporter The Town of Huntington’s (NY) board meeting, on April 11, 2024, was a truly unforgettable experience for me, as I had the honor of receiving a proclamation on behalf of FPN (the Foundation for Peripheral Neuropathy) for Peripheral Neuropathy Awareness Week. It was an incredibly touching and …
Help Advocate for Government Funding for Peripheral Neuropathy Research in 2025 Due to the Foundation for Peripheral Neuropathy’s (FPN) advocacy efforts on the Hill, and countless letters from PN patients like you, Congress designated peripheral neuropathy as a condition in the Peer Reviewed Medical Research Program (PRMRP) in the annual Defense Appropriations Act during fiscal …
Make Your Voice Heard: Join the Call to Action for PN Advocacy! Read More »
On March 23, 2024, the Senate Committee on Appropriations approved, by a large bipartisan vote, the Senate version of the fiscal year 2024 Defense Appropriations Bill. As it has in the three previous years (FY21-23), the Committee renewed “peripheral neuropathy” (PN) as an eligible condition for receiving research grants from the Department of Defense’s Peer Reviewed …
